CureVac N.V. financials at a glance
| Year | Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$17.42M | $48.87M | $102.99M | $67.42M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
-59.72% | 71.10% | -109.02% | -135.79% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | -273.27% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-0.98 | $-4.18 | $-1.32 | $-0.91 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | -0.00% | -0.00% | -0.00% | -0.00% | 0 |
| Sha. | Shares |
|
0m | 176.46m | 187.05m | 187.05m | 223.92m | 223.92m |
| OCF | Operating Cash Flow |
|
$-86.96M | $522.40M | $-733.13M | $-286.18M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-98.13M | $486.07M | $-857.35M | $-374.20M | $-138.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.03 | $3.59 | $-4.63 | $-2.01 | $0.00 | $0.00 |